HIV Duel therapy approval tomorrow and throw in a COVID-19
HIV Duel therapy approval tomorrow and throw in a COVID-19 mild to moderate approvals as well as the FDA announces that they have found the therapeutic to treat the masses.
You all have been very logical in attacking every angle to figure out what is going to happen this week in the two meetings of the FDA and the MHRA. I commend you all for your ideas and speculation. Many good views and predictions. My thoughts above In the first paragraph are of coarse the overly optimistic view we all wish for but know we are not quite there just yet.
The two meetings this week might or might not be talked about by Cytodyn this week. We may not have a Proactive video or any type of press release whatsoever. Think about how rampart our chat board will be speculating about the meetings and what went on and what no communication means... Whew... lots to read this week if that happens.
I am of the opinion that we have been in discussions for a few weeks now with the FDA and OWS and the simple fact is we couldn’t be awarded anything until we were able to manufacture enough vials to help in this pandemic. No use getting an approval unless you have stock to distribute to the masses at least in this country and ramp up International production to serve many other countries. That being said. If we were to get the approvals with minimal resources of Leronlimab and Leronlimabs story was told on every news media channel and Newspaper. Then it couldn’t be found anywhere at any hospital until production was ramped up. The averages Joe or the total population would believe that the rich and famous must be getting it and the average person just has to wait. This is not a scenario that the government of any country would like. So, my thoughts were the past few weeks since we announced our results of the M&M results we have been ramping up secretly. Starting the progression to distribute and to not fail the people. The BLA’s or EUA’s of the world were always coming but production production production was the issue and the reason we have waited for announcements.
So everyone that doesn’t need to know. Will know soon enough. These meetings will be just the steps needed to start the speculation of a imminent approval. I like my view because it is overly opportunistic.
As you can see... I live in a bright sunny world where everything works out and all of our dreams come true. Wow... if it were only that easy huh? Let’s hope for the best and save as many lives as possible. That’s all that really matters. Everything else will work itself out in time if it was meant to be. I believe! I have always believed!
Just having fun... of coarse my speculation is just great fiction. It’s a world I would love to live in though.
GLTU
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigation Into SecureWorks Corp. Shareholder Fairness In recent developments, Ademi LLP has initiated an investigation into SecureWorks Corp. (NASDAQ: SCWX) concerning possible breaches of fiduciary duty related to its upcoming transaction with Sophos. This investigation raises important questions about whether SecureWorks is providing fair value to its public...
Continue Reading
VIAVI Partners with Telefónica HISPAM for Enhanced Network Management Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) recently secured a strategic agreement to provide advanced automated network inventory management for Telefónica Hispanoamérica (HISPAM). This collaboration aims to leverage Viavi's innovative NITRO AIOps solution to improve network operations throughout...
Continue Reading
Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...
Continue Reading
Teads Holding Co. Engages Investors in Upcoming Conferences Teads Holding Co. (NASDAQ: TEAD), recognized as a leader in the advertising technology space, is gearing up for significant investor conferences this September. As the company continues to expand its influence and reach, it will showcase its innovative approach to marketing solutions at these events, emphasizing...
Continue Reading
Overview of the Intelligent Vending Machines Market The Intelligent Vending Machines market is undergoing rapid transformation, capturing the interest of both investors and consumers alike. As technology progresses at an astonishing pace, these machines are evolving from simple snack dispensers into advanced retail solutions. Currently valued at USD 22.15 billion, the...
Continue Reading